X Biotech Usa
Biotechnology, 5217 Winnebago Ln, Austin, Texas, 78744, United States, 51-200 Employees
Who is XBIOTECH USA
XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True HumanTM prop...
Read More
-
Headquarters: 5217 Winnebago Ln, Austin, Texas, 78744, United States
-
Date Founded: 2005
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
John Simard
Email
Phone
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 621999 |
Show More
Does something look wrong? Fix it. | View contact records from XBIOTECH USA
XBiotech USA Org Chart and Mapping
Similar Companies to XBiotech USA
Aeglea BioTherapeutics
-
51-200
-
$ 25 Million to 50 Million
Asuragen
-
51-200
-
$ 50 Million to 100 Million
Luminex Corporation - A Diasorin Company
-
501-1000
-
$ 250 Million to 500 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding XBiotech USA
Answer: XBiotech USA's headquarters are located at 5217 Winnebago Ln, Austin, Texas, 78744, United States
Answer: XBiotech USA's official website is https://xbiotech.com
Answer: XBiotech USA's revenue is $10 Million to $25 Million
Answer: XBiotech USA's SIC: 2834
Answer: XBiotech USA's NAICS: 621999
Answer: XBiotech USA has 51-200 employees
Answer: XBiotech USA is in Biotechnology
Answer: XBiotech USA top competitors include: Aeglea BioTherapeutics , Asuragen , Luminex Corporation - A Diasorin Company
Answer: XBiotech USA contact info: Phone number: Website: https://xbiotech.com
Answer: XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True HumanTM proprietary technology. Unlike previous generations of antibody therapies, XBiotechs True HumanTM antibodies are 100 percent human, derived from individuals who possess natural immunity to certain diseases. With discovery and clinical programs across multiple disease areas, XBiotechs True HumanTM antibodies have the potential to harness the bodys natural immunity to fight disease with increased safety, efficacy and tolerability. XBiotech is currently advancing a robust pipeline of antibody therapies to exceed the standards of care in oncology, inflammatory conditions and infectious diseases. The Company's broad pipeline of True HumanTM antibodies are able to potentially deliver unmatched safety and efficacy because they are cloned directly from individual donors who possess natural immunity against certain targeted diseases. As such, True HumanTM antibodies retain their natural physiology and tolerance profile, having passed the rigors of immune selection in the body.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month